1. Aguilera, C., Hauger, R. L., and Catt, K. J., 1978, Control of aldosterone secretion during sodium restriction: Adrenal receptor regulation and increased adrenal sensitivity to angiotensin II, Proc. Natl. Acad. Sci. U.S.A. 75: 959–979.
2. Ariens, E. J., 1954, Affinity and intrinsic activity in the theory of competitive inhibition, Arch. Int. Pharmacodyn. 99: 32–49.
3. Armstrong, G. D., and Hollenberg, M. D., 1982, Crosslink-labeling and proteolytic mapping of the human placental receptor for epidermal growth factor-urogastrone, Proc. Can. Fed. Biol. Soc. 25: 15.
4. Arunlakshana, O., and Schild, H. O., 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14: 48–58.
5. Baker, J. B., Barsh, G. S., Carney, D. H., and Cunningham, D. D., 1978, Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture, Proc. Natl. Acad. Sci. U.S.A. 75: 1882–1886.